Anthrax Articles | Global Biodefense

Anthrax

Biodefense Headlines – 30 December 2024

News Scan December 30, 2024

This week’s selections include California’s declaration of a bird flu emergency (and calls to do so nationally), the first severe case of H5N1 in the U.S., the risks of advancing…

Anthrax

FDA Lifts Clinical Hold On PharmAthene’s Anthrax Vaccine Program

New Kind of Antibiotic May Be More Effective Against Biothreats

Goodwin Biotechnology Awarded Sub-Contract for Anthrax Vaccine

Notable Contracts: Cempra Biodefense Antibiotic for Children

Soligenix Thermostable Biodefense Vaccine Technology Patent

GAO Says 60 Percent of CBRN National Stockpile Approved for Children

CBRN Diagnostics Broad Agency Announcement

Second Suspicious Letter Intercepted, Addressed to POTUS

Bacillus ACT 2013 – International Anthrax Conference

Biodetection Technologies for First Responders

Sandia: New Instrument to Quickly Detect Botulinum, Ricin, Other Biothreats

Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research

EPA Study: Bioterror Agent Decontamination Sampling

FDA Approves Raxibacumab to Treat Inhalational Anthrax

NIAID Award to Fraunhofer, iBio for Anthrax Vaccine

NIAID Awards Funding for Non-Needle Anthrax Vaccine

Anthrax Guidance for First Responders

BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine

iBio Expands Plant-Based Vaccine Biodefense Portfolio

Government to Amend Select Agents and Toxins List

Biodefense Headlines – 30 December 2024